Skip to main content
. 2013 Mar 16;471(10):3171–3177. doi: 10.1007/s11999-013-2917-7

Table 4.

Description of positive fungal culture cases and subsequent treatment*

Case Hip/knee Indication Number of cultures sent Number of positive cultures Organism Treatment Subsequent infection cultures Followup (months)
1 Knee PJI Stage 2 4 1 Candida albicans/Enterobacter cloacae No NA 6
2 Knee Loosening 4 1 Alternaria/coagulase-negative Staphylococcus No NA 62
3 Hip PJI Stage 2 4 1 Penicillium Voriconazole NA 32
4 Knee PJI Stage 2 3 1 Aspergillus No NA 79
5 Hip Loosening 3 1 Cladosporium No NA 25
6 Hip Loosening 3 1 Penicillium No NA 39
7 Knee Loosening 3 1 Aureobasidium No NA 75
8 Knee PJI Stage 2 3 1 Candida albicans No NA 1
9 Hip PJI Stage 2 3 1 Aspergillus fumigatus No NA 3
10 Hip PJI Stage 2 3 1 Dematiaceous No NA 27
11 Hip Loosening 3 1 Penicillium No NA 42
12 Hip PJI Stage 2 2 1 Paecilomyces No NA 82
13 Hip PPFx 2 1 Penicillium No NA 2
14 Hip Instability 2 1 Rhodotorula minuta Caspofungin NA 79
15 Hip PJI Stage 2 2 1 Candida albicans No NA 67
16 Hip Loosening 1 1 Rhodotorula No NA 38
17 Knee PJI Stage 2 1 1 Penicillium No NA 15
18 Hip PJI Stage 2 2 1 Candida albicans/VRE Fluconazole VRE 39
19 Knee Loosening 1 1 Candida parapsilosis No Candida parapsilosis, MSSA 47

* Only patients with a minimum followup of 12 months were included in the analysis of true-/false-positive rates; PJI = periprosthetic joint infection; PPFx = periprosthetic fracture; VRE = vancomycin-resistant Enterococcus; MSSA = methicillin-sensitive Staphylococcus aureus; NA = not applicable.